Aligos Therapeutics (ALGS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Aligos Therapeutics Revenue Highlights


Latest Revenue (Y)

$15.53M

0

Aligos Therapeutics Revenue by Period


Aligos Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$15.53M11.66%
2022-12-31$13.91M219.04%
2021-12-31$4.36M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Aligos Therapeutics generated $15.53M in revenue during NA 2023, up 11.66% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Aligos Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--100.00%
2024-03-31$986.00K-63.22%
2023-12-31$2.68M-17.23%
2023-09-30$3.24M-52.96%
2023-06-30$6.89M152.88%
2023-03-31$2.72M-23.01%
2022-12-31$3.54M-13.86%
2022-09-30$4.11M11.18%
2022-06-30$3.69M43.64%
2022-03-31$2.57M600.54%
2021-12-31$367.00K-76.12%
2021-09-30$1.54M-0.52%
2021-06-30$1.54M69.78%
2021-03-31$910.00K100.00%
2020-12-31--100.00%
2020-09-30$2.03M100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-06-30-100.00%
2018-03-31--

Aligos Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Aligos Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$25.11M
SPROSpero Therapeutics$96.73M$10.20M
ALGSAligos Therapeutics$15.53M-
ASMBAssembly Biosciences$7.16M$5.79M
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$1.44M

ALGS Revenue FAQ


Aligos Therapeutics's yearly revenue for 2023 was $15.53M, representing an increase of 11.66% compared to 2022. The company's yearly revenue for 2022 was $13.91M, representing an increase of 219.04% compared to 2021. ALGS's yearly revenue for 2021 was $4.36M, representing an increase of 100.00% compared to 2020.

Aligos Therapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $986K, a -63.22% decrease from the previous quarter (Q4 2023), and a -63.79% decrease year-over-year (Q1 2023). ALGS's quarterly revenue for Q4 2023 was $2.68M, a -17.23% decrease from the previous quarter (Q3 2023), and a -24.20% decrease year-over-year (Q4 2022).

Aligos Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 256.25%, and for the last 5 years (2019-2023) was 0%.